Work

Phase 2a study of CM-101, a CCL24 neutralizing antibody, in patients with non-alcoholic steatohepatitis: a proof-of-concept study

Year: 2023

Type: article

Source: Journal of Hepatology

DOI: 10.1016/s0168-8278(23)00610-4

Authors: Rifaat Safadi, John Lawler, Revital Aricha, Ilan Vaknin, Scott Friedman, Adi Mor

Language: English

Topic: Liver Disease Diagnosis and Treatment

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4385079452

FWCI: 0.334

Cites:

Cited by: 2

Related to: 10